Home
›
Videos
›
Dermbits
›
Concerns Use Il 23 Il 17 Inhibitors Cscc
Are there any concerns with the use of IL-23 or IL-17 inhibitors in patients with a history of cutaneous squamous cell carcinoma (cSCC)?
Featuring:
AA
April Armstrong, MD, MPH
Co-Director
Updated:
Aug 18, 2026
Psoriasis